As part of its efforts to ramp up the testing capacity, the Indian Council of Medical Research (ICMR) has approved the use of diagnostic machines used for testing drug-resistant tuberculosis for conducting coronavirus tests.
The ICMR has validated 'TruenatTM beta CoV test on TruelabTM workstation' and has recommended it as a screening test, the apex health research body said today.
Issuing a guidance on the use of Truenat beta CoV, the ICMR said throat/nasal swabs will be collected in the viral transport medium (VTM) with virus lysis buffer provided along with the kit.
"Earlier studies have shown that virus lysis buffer neutralizes Nipah and H1N1 viruses. The results of stability of viral RNA after neutralization of SARS-CoV-2 by virus lysis buffer are awaited from ICMR-NIV, Pune.
"Till such time, Truenat beta CoV test should only be performed with all biosafety precautions in BSL-2 or BSL-3 setups at laboratories," it said.
The revised guidelines will be issued once the results from ICMR-NIV, Pune are available, it said.
Bharat Biotech Adds Top Medical Body ICMR As Co-Owner Of Covid Vaccine Patent Top Medical Body ICMR Warns Against Overcooking Dal, Saying It May Affect Nutritional Value Top Medical Body ICMR Advises People To Buy Whole Spices To Avoid Adulteration Newly Married Indian-Origin Man Shot Dead In US In Suspected Road Rage 14 Work Hours A Day, 70 A Week: Karnataka Plans New Bill For Techies Bangladesh Top Court Scales Back Jobs Quota That Sparked Deadly Violence Netanyahu To Face US Congress, Meet Biden At White House Iraq To Import Electricity From Turkey Odisha Pradesh Congress Committee Dissolved By Mallikarjun Kharge Track Latest News Live on NDTV.com and get news updates from India and around the world.